US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.91

+0.25501.37%

Post-market: 18.910.00000.00%16:10 EDT

Volume:10.43K

Turnover:195.98K

Market Cap:109.70M

PE:- -

High:18.91

Open:18.83

Low:18.67

Close:18.66

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:0.35

T/O Rate:0.18%

Dividend:0.71

Dividend Rate:3.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%

MT Newswires Live

CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion

CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million

THOMSON REUTERS

CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026

THOMSON REUTERS

Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing

Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use

Simply Wall St.

CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors

Wuxi Biologics (Cayman) Stock Falls 1.4% in Hong Kong

Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?

Simply Wall St.

Innovent Biologics (SEHK:1801), Why Is It Back In The Spotlight?

Simply Wall St.

CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer

Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut

CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live

Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates

Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer

CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS

CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer

THOMSON REUTERS

WuXi Biologics Wins BioPharma APAC Spot on 2026 Sustainable Biopharma List

WuXi XDC Secures GMP Release for BCM3 Bioconjugate Production Line in Singapore

CSPC Innovation Posts RMB 1.26 Billion H1 Net Profit on RMB 3.24 Billion Revenue

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/KURE/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.91,"timestamp":1788465600000,"preClose":18.655,"halted":0,"volume":10429,"hourTrading":{"tag":"盘后","latestPrice":18.91,"preClose":18.91,"latestTime":"16:10 EDT","volume":10,"amount":189.1,"timestamp":1788466205561,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.013669257571696541,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Post-Mkt","change":0.255,"latestTime":"09-03 16:46:55 EDT","open":18.83,"high":18.91,"low":18.6655,"amount":195976,"amplitude":0.013106,"askPrice":20.61,"askSize":100,"bidPrice":17.09,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788480000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.655,"sharesOutstanding":4750002,"nav":18.46,"aum":108936686.05,"dividendRate":0.0378,"bidAskSpread":0.00342,"postHourTrading":{"tag":"盘后","latestPrice":18.91,"preClose":18.91,"latestTime":"16:10 EDT","volume":10,"amount":189.1,"timestamp":1788466205561,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.349371,"impliedVol":0.2767,"impliedVolPercentile":0.5754},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.349371,"shares":5800979,"dividePrice":0.7148,"high":18.91,"amplitude":0.013106,"preClose":18.655,"low":18.6655,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.91,"eps":0,"divideRate":0.0378,"volume":10429,"delay":0,"ttmEps":0,"open":18.83,"prevYearClose":17.04,"prevWeekClose":18.925,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":19.215,"twentyDayClose":17.47,"sixtyDayClose":14.5156},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660403998","title":"CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403998","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403998?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:09","pubTimestamp":1787202587,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  reported an over 139% jump in attributable profit for the first half of 2026 to 6.09 billion yuan from 2.55 billion yuan a year earlier, according to a Thursday Hong Kong bourse filing.Earnings per share for the six months ended June 30 climbed to 0.5336 yuan from 0.2229 yuan in the prior-year period.Revenue of the pharma company jumped 40.1% year on year to 18.6 billion yuan from 13.3 billion yuan.The company declared an interim dividend of HK$0.18 per share, payable on Nov. 10 to shareholders of record on Oct. 26.Shares of the company jumped nearly 14% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","LU0315179316.USD","LU2039709279.SGD","HK0000165453.HKD","LU0072913022.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","LU0140636845.USD","BK1521","LU1226288253.USD","IE00BZ08YT58.USD","SG9999004220.SGD","IE00B5MMRT66.SGD","LU1807302812.USD","IE00B543WZ88.USD","LU0314109678.HKD","IE00B031HY20.USD","LU0501845795.SGD","01093","LU1328277881.USD","BK1191","LU1226287529.USD","LU1226287875.USD","IE0008368742.USD","LU1226288170.HKD","LU1993786604.SGD","LU1008478684.HKD","LU0067412154.USD","LU0880133367.SGD","FCA","KURE","LU1152091168.USD","LU1813983027.USD","IE0008369823.USD","LU0326950275.SGD","LU1960683339.HKD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660906408","title":"CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660906408","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660906408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:19","pubTimestamp":1787199569,"startTime":"0","endTime":"0","summary":"CSPC Pharma FY26 H1 profit attributable to shareholders more than doubled to RMB 6.09 billion; revenue rises 40.1% to RMB 18.59 billionCSPC Pharmaceutical posted first-half revenue of RMB 18.59 billio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6XHzX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008368742.USD","LU1226287792.SGD","LU1226288170.HKD","LU1152091168.USD","01093","LU0880133367.SGD","LU1951186391.HKD","LU2039709279.SGD","BK1191","LU0140636845.USD","LU0326950275.SGD","LU1807302812.USD","LU1226288253.USD","IE0008369823.USD","IE00BZ08YR35.GBP","LU1813983027.USD","LU0315179316.USD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","LU1328277881.USD","LU1226287529.USD","LU1993786604.SGD","LU0501845795.SGD","KURE","BK1521","LU1008478684.HKD","LU0314109678.HKD","HK0000165453.HKD","LU1226287875.USD","LU0072913022.USD","IE00B5MMRT66.SGD","LU0067412154.USD","BK1515","IE00BZ08YT58.USD","IE00B031HY20.USD","LU1960683339.HKD","LU1152091754.HKD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660408970","title":"CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660408970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660408970?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:18","pubTimestamp":1787199533,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXV00X44:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1328277881.USD","LU0314109678.HKD","LU1993786604.SGD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1960683339.HKD","IE00BZ08YT58.USD","LU1152091754.HKD","HK0000165453.HKD","LU2039709279.SGD","01093","LU1008478684.HKD","LU1226287792.SGD","LU1951186391.HKD","BK1515","LU1226288170.HKD","LU1226288253.USD","LU0140636845.USD","LU0315179316.USD","LU1152091168.USD","LU1226287875.USD","LU1813983027.USD","LU0501845795.SGD","IE00B5MMRT66.SGD","KURE","LU0326950275.SGD","IE0008368742.USD","LU0067412154.USD","BK1521","BK1191","LU0880133367.SGD","IE0008369823.USD","SG9999004220.SGD","LU1226287529.USD","IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660140897","title":"CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660140897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660140897?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:18","pubTimestamp":1787199533,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXV00X44:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1951186391.HKD","LU1993786604.SGD","01093","LU0880133367.SGD","LU1813983027.USD","IE0008368742.USD","LU0501845795.SGD","BK1191","IE00BZ08YR35.GBP","LU1960683339.HKD","BK1521","LU0067412154.USD","LU1226287529.USD","LU1226287875.USD","IE0008369823.USD","IE00B031HY20.USD","LU1328277881.USD","LU0315179316.USD","LU0326950275.SGD","SG9999004220.SGD","IE00BZ08YT58.USD","LU0314109678.HKD","LU0072913022.USD","BK1515","LU1226288253.USD","LU1807302812.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1152091168.USD","LU1008478684.HKD","IE00BZ08YS42.EUR","LU1152091754.HKD","IE00B543WZ88.USD","LU2039709279.SGD","LU0140636845.USD","LU1226287792.SGD","LU1226288170.HKD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197259183","title":"Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing","url":"https://stock-news.laohu8.com/highlight/detail?id=1197259183","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197259183?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:38","pubTimestamp":1787182701,"startTime":"0","endTime":"0","summary":"On August 20, the Nasdaq Biotechnology Index jumped 6.39%, marking its largest single-day gain in six years. Moderna soared 176.97%, adding $44 billion in market value, while Merck closed up 12.6%,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","LU3063872942.SGD","LU0979878070.USD","LU0417516902.SGD","LU0823426308.USD","VXUS","LU0348735423.USD","LU2039709279.SGD","LU0043850808.USD","LU0708995583.HKD","LU0327786744.USD","LU0456827905.SGD","LU0572944931.SGD","LU0307460666.USD","LU0320764599.SGD","LU0181495838.USD","LU1688375341.USD","LU0417516738.SGD","LU0588546209.SGD","LU0856984785.SGD","LU0516423174.USD","LU0516422366.SGD","LU1794554557.SGD","BK1141","LU0456846285.SGD","LU0823426480.USD","BK4588","LU0052750758.USD","LU0516422440.USD","LU0516423091.SGD","LU0359201612.USD","02269","BK1610","SG9999002562.SGD","IE00B0JY6N72.USD","KCAI","01244","LU0819121731.USD","BK1521","BK4585","LU0326950275.SGD","LU0348825331.USD","BK1161","SG9999002463.SGD","LU0140636845.USD","LU1720050803.USD","LU1242518931.SGD","LU1242518857.USD","WDNA","KURE","BK1576","LU0039217434.USD","BK1589","LU0359202008.SGD","LU1880383366.USD","LU0029874061.USD","LU0051755006.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660244894","title":"Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244894","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244894?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:20","pubTimestamp":1787149244,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) is back in focus after China’s National Medical Products Administration approved ivonescimab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.\nSee our latest analysis for Akeso.\nDespite the positive ivonescimab news, Akeso’s share price has come under pressure, with the stock down 12.54% over the past week and 21.18% year to date. At the same time, the 3 year total shareholder return of 185.76% and 5 year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0348784397.USD","LU2476274720.SGD","LU0348825331.USD","IE00B5MMRT66.SGD","LU0348827113.USD","LU1720050803.USD","BK1161","LU0634319403.HKD","IE00B543WZ88.USD","LU0540923850.HKD","LU0348735423.USD","LU2778985437.USD","LU0417516571.SGD","LU0417516902.SGD","BK1574","LU2399975544.HKD","09926","LU1961090484.USD","LU1794554557.SGD","LU0348767384.USD","LU0417516738.SGD","LU2476274308.USD","IE00BPRC5H50.USD","KURE","LU2488822045.USD","LU0561508036.HKD","LU0348766576.USD","LU0348783233.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453474","title":"CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453474","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453474?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:33","pubTimestamp":1787128380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 1.3% to 8.69 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25495.07.The stock's fall snapped a two-day winning streak.CSPC Pharmaceutical Group Ltd. closed 25% below its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.1%, SSY Group Ltd. fell 0.6%, and United Laboratories International Holdings Ltd. fell 1.4%.Trading volume totaled 67.4 million shares, compared to the 50-day average of 92.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0067412154.USD","IE00B031HY20.USD","LU1226287792.SGD","LU1226287875.USD","LU0072913022.USD","HK0000165453.HKD","LU1813983027.USD","LU1960683339.HKD","LU1993786604.SGD","KURE","LU1807302812.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1226288170.HKD","LU1226287529.USD","LU1226288253.USD","BK1521","01093","LU0140636845.USD","LU1152091168.USD","SG9999004220.SGD","LU1152091754.HKD","LU0326950275.SGD","BK1191","LU1008478684.HKD","IE00BZ08YS42.EUR","LU2039709279.SGD","IE0008368742.USD","LU0314109678.HKD","LU1328277881.USD","IE0008369823.USD","LU0501845795.SGD","LU0315179316.USD","LU0880133367.SGD","BK1515","LU1951186391.HKD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445379","title":"Wuxi Biologics (Cayman) Stock Falls 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445379","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445379?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:33","pubTimestamp":1787128380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 1.4% to 47.90 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25495.07.The stock's fall snapped a two-day winning streak.Wuxi Biologics  Inc. closed 2.2% below its 52-week high of HK$49.00, which the company achieved Aug. 18.Trading volume totaled 32.0 million shares, compared to the 50-day average of 35.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0348825331.USD","LU0456846285.SGD","LU0181495838.USD","LU0516422440.USD","LU0320764599.SGD","LU1242518857.USD","LU0051755006.USD","SG9999002562.SGD","LU0029874061.USD","BK1610","BK1521","BK1141","LU0819121731.USD","LU1720050803.USD","LU0128526141.USD","LU0043850808.USD","LU0856984785.SGD","LU1880383366.USD","LU0516422952.EUR","SG9999002463.SGD","02269","LU0348735423.USD","LU0359202008.SGD","LU0979878070.USD","LU0417516902.SGD","LU0456827905.SGD","LU0327786744.USD","LU0307460666.USD","LU0140636845.USD","LU0588546209.SGD","LU0572944931.SGD","LU1794554557.SGD","LU0326950275.SGD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0417516738.SGD","LU0516423174.USD","KURE","LU1688375341.USD","LU0516422366.SGD","LU0708995583.HKD","LU0823426308.USD","LU2039709279.SGD","BK1589","LU0823426480.USD","LU1242518931.SGD","LU0052750758.USD","LU0039217434.USD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480614","title":"Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480614","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480614?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:12","pubTimestamp":1787116367,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group recently reported three developments: U.S. FDA approval to begin clinical trials for its mpox mRNA vaccine, a US$10,000,000 milestone payment from AstraZeneca tied to their small-molecule collaboration, and a joint venture with AstraZeneca to build a biologics manufacturing facility in Shijiazhuang, China.\nTogether, these moves expand CSPC’s innovative vaccine and drug pipeline while pushing its manufacturing and quality systems further onto the global stage.\nWe’ll...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BZ08YT58.USD","LU1226288170.HKD","BK4588","LU1813983027.USD","BK4585","LU1951186391.HKD","HK0000165453.HKD","LU0140636845.USD","LU1993786604.SGD","LU1328277881.USD","LU0326950275.SGD","LU0314109678.HKD","BK1191","SG9999004220.SGD","LU1226287529.USD","LU1226287792.SGD","LU1807302812.USD","LU1152091168.USD","LABU","LU0315179316.USD","LU2039709279.SGD","IE00B543WZ88.USD","LU1152091754.HKD","LU0072913022.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1960683339.HKD","KURE","BK1521","LU1226287875.USD","IE0008369823.USD","LU1008478684.HKD","BK1515","01093","LU1226288253.USD","IE0008368742.USD","LU0880133367.SGD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU0067412154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494056","title":"Innovent Biologics (SEHK:1801), Why Is It Back In The Spotlight?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494056","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494056?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:24","pubTimestamp":1787070276,"startTime":"0","endTime":"0","summary":"Innovent Biologics (SEHK:1801) caught investor attention after reporting product revenue of over CN¥4.3b for Q2 2026 and more than CN¥8.2b for the first half, supported by its dual engine growth strategy.\nSee our latest analysis for Innovent Biologics.\nThose revenue headlines have arrived alongside firm share price momentum, with Innovent Biologics delivering a 30 day share price return of 8.66% and a 90 day share price return of 21.73%, while the three year total shareholder return of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/innovent-biologics-sehk1801-why-is-it-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/innovent-biologics-sehk1801-why-is-it-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01801","LU2097828714.EUR","BK1583","LU2328871848.SGD","LU0455707207.USD","HK0000165453.HKD","DCF","LU2097828474.EUR","LU2097828557.USD","LU2242644610.SGD","LU0463099449.HKD","BK1161","BK1589","LU2097828805.USD","KURE","LU0326950275.SGD","LU1188198961.HKD","LU0244354667.USD","LU2488822045.USD","LU0502904849.HKD","LU1969619763.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660951444","title":"CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660951444","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660951444?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:22","pubTimestamp":1787066521,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharma Says NMPA Accepts NDA For KN026 And HB1801 For Advanced Breast CancerAug 18 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:NMPA ACCEPTS NEW DRUG APPLICATION FOR KN026 AND HB1801 FOR ADVANCED BREAST CANCERFurther company coverage:1093.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1152091168.USD","LU1226287529.USD","LU1328277881.USD","LU1152091754.HKD","LU1807302812.USD","LU1008478684.HKD","LU1951186391.HKD","HK0000165453.HKD","IE00B031HY20.USD","LU1226287792.SGD","LU0880133367.SGD","BK1515","IE0008369823.USD","LU0072913022.USD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU0314109678.HKD","LU0067412154.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU2039709279.SGD","01093","LU0501845795.SGD","LU1226288170.HKD","BK1521","KURE","LU0140636845.USD","LU1960683339.HKD","IE00BZ08YT58.USD","IE0008368742.USD","LU0315179316.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","SG9999004220.SGD","BK1191","LU1226287875.USD","LU1813983027.USD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108049588","title":"Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1108049588","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108049588?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:04","pubTimestamp":1787058250,"startTime":"0","endTime":"0","summary":"External uncertainties persisted, yet both markets demonstrated resilience as Hong Kong equities edged up 0.07% on the day. The 60-day negotiation window outlined in the US-Iran memorandum of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU1956131251.USD","BK1516","AAXJ","LU0211977185.USD","LU0823040885.USD","LU0455707207.USD","LU0384037296.USD","LU1831875114.USD","LU0231483743.USD","LU2462611646.USD","BK1584","KURE","SG9999001903.USD","BK1521","LU0417516902.SGD","TCHmain","LU1960683339.HKD","LU0886674414.USD","LU0049853897.USD","LU0594300179.USD","LU1242518857.USD","LU1868838027.USD","LU2008162690.USD","LU1883866441.USD","00316","LU1226288097.SGD","LU1224709979.USD","09988","BK1609","LU1785774172.SGD","LU1769817179.HKD","SG9999002562.SGD","LU1568876251.USD","01117","LU1044874839.SGD","LU0328353924.USD","LU0054237671.USD","LU1814569148.SGD","LU0261947096.USD","LU0080751232.USD","LU2242644610.SGD","LU0067412154.USD","LU0196878994.USD","BK1517","LU1366334578.USD","LU0043850808.USD","LU0502904849.HKD","LU0737861699.HKD","LU0572944931.SGD","SG9999014906.USD","IE00B12V2V27.USD","LU1226287875.USD","LU0828237510.HKD","LU1808992512.USD","BK1610","IE00BYQNZ168.SGD","LU0054450605.USD","DRGN","LU0210526637.USD","IE00B29SXG58.USD","HK0000306701.USD","LU1568876335.HKD","WXXWY","LU0048580855.USD","BK1553","IE00B97KM107.HKD","SG9999015945.SGD","LU0516422366.SGD","BK1575","IE00BZ08YT58.USD","LU1251922891.USD","HK0000286598.CNH","LU0593848301.USD","ROBO","SG9999003461.SGD","LU2449936058.SGD","LU1981816686.USD","TCEHY","LU0737861772.HKD","BK1212","BKF","LU0096374516.USD","LU0329678170.USD","IE0003895053.USD","LU0878005551.USD","LU1226287529.USD","BK1608","LU0149721374.USD","LU2476274720.SGD","LU0572939691.SGD","09676","LU1048588211.SGD","LU1051769294.HKD","LU1481107354.HKD","LU1629966141.USD","LU0642271901.SGD","LU1880398554.USD","LU0348805143.USD","BK1502","LU1734074674.USD","LU1226288253.USD","LU1691799644.USD","BK1103","LU0871576103.HKD","LU1733274473.HKD","LU0797268264.HKD","FFEM","LU0509642566.USD","LU2251237306.USD","LU0608807946.USD","LU1115378108.SGD","LU0173614495.USD","BK1501","LU1323998911.USD","LU2237443382.USD","SG9999001093.SGD","LU0589944569.HKD","LU0516422952.EUR","LU0791591158.USD","LU1303224171.USD","LU0175139822.USD","LU1810669033.SGD","HK0000151867.HKD","LU2778985437.USD","00700","SG9999000327.SGD","LU0823397103.USD","LU0708995153.HKD","SG9999004220.SGD","LU2294711473.HKD","LU1196710864.SGD","LU1224444064.USD","IE0001KFT4U8.USD","IE00BYTNYN87.SGD","LU0878004406.USD","SG9999014898.SGD","LU0541501648.USD","LU0762541174.USD","LU0049112450.USD","LU1974910355.USD","LU0128522157.USD","LU0203345920.USD","SG9999014674.SGD","LU2045819591.USD","LU2097829019.USD","LU2498475776.HKD","LU1725190679.HKD","BK1583","JEMA","02715","LU0634319403.HKD","LKHLY","LU2152927971.USD","LU0320764243.SGD","LU0607220059.USD","HBBD.SI","LU1023057109.AUD","LU1548497426.USD","SGXZ86797644.SGD","SGXZ31699556.SGD","LU0577902298.EUR","LU0499858602.USD","SEA","LU0203347892.USD","LU0326948709.USD","LU0588545904.SGD","LU0163747925.USD","LU0128522744.USD","SG9999001689.USD","LU0052750758.USD","LU0106259558.USD","LU0348827113.USD","LU0414403682.SGD","LU0264606111.USD","LU0633140727.USD","BK1591","EMCS","CXSE","IE0031814852.USD","BIDD","LU0708995583.HKD","LU0675040207.SGD","SGXZ62798434.SGD","SGXZ99366536.SGD","LU0130518102.USD","LU0823039010.USD","LU1642822792.SGD","LU2097828474.EUR","IE00B8HQ1Z84.USD","LU0417516738.SGD","FDNI","LU0516423174.USD","LU0320764755.SGD","02050","LU0819123356.HKD","LU0449515922.USD","LU2362541273.HKD","00354","BK1526","LU2476274308.USD","SG9999002950.SGD","LU1196710351.USD","LU0605514214.HKD","06683","LU1282648689.USD","LU0348814723.USD","LU0127658192.USD","ESPO","IE00BMPRXN33.USD","LU0918141705.HKD","09858","BK1237","LU1048484197.HKD","HK0000352382.USD","LU1813983027.USD","LU0648948544.HKD","LU0577902454.USD","LU2097828714.EUR","LU0633140560.USD","BK1613","LU0072913022.USD","LU2279701549.SGD","SG9999006597.SGD","LU1282649141.HKD","LU1282651048.USD","LU0106252389.USD","LU2133065610.SGD","LU0784639295.USD","03888","LU0254981946.USD","SG9999011746.SGD","LU0488056044.USD","LU0700851271.USD","LU0477156797.USD","LU0149534421.HKD","LU2097828557.USD","LU0738912210.USD","LU0516423091.SGD","LU0061477393.USD","LU1044875133.USD","IE0032431581.USD","LU0862451837.USD","LU1046422090.SGD","LU0164872284.USD","LU2237443978.SGD","LU0197773160.USD","LU1733274390.USD","LU1196710195.USD","LU1770036033.HKD","LU0608807433.USD","LU1188198961.HKD","IE00BGV7N243.SGD","LU0831093199.SGD","LU0456827905.SGD","LU0348723411.USD","LU1655091459.SGD","LU0314109678.HKD","BK1576","IE00BZ08YR35.GBP","LU0130103400.USD","LU1235295612.USD","LU0650527681.SGD","LU2125910500.SGD","SG9999001846.SGD","SG9999014880.SGD","LU0084288322.USD","LU0348788117.USD","02268","LU2148510915.USD","BOAT","LU2251237488.HKD","LU1951186391.HKD","LU1282649067.USD","LU0588545730.USD","LU0293314216.USD","LU0164880469.USD","HK0000306685.HKD","LU0898667661.SGD","LU2237443622.USD","LU0823397285.USD","LU0463099449.HKD","01548","LU0348825331.USD","LU0261950983.USD","LU1102505929.USD","LU1328615791.USD","LU0786609619.USD","BK1144","LU0047713382.USD","LU0577902611.USD","LU2087589342.USD","LU2279858448.HKD","LU0117841782.USD","EMC","LU0417516571.SGD","LU0823413587.USD","LU0651946864.USD","LU0251144936.SGD","LU0441854154.USD","HK0001040143.USD","LU0449509016.USD","LU0348784397.USD","LU2357305700.SGD","LU0269904917.USD","BK1509","GAMR","LU0396098781.USD","02419","LU1152091754.HKD","IE0008368304.USD","LU0143863198.USD","LU0132412106.USD","HTCD.SI","SGXZ90724238.SGD","LU2257852520.SGD","BK1141","HK0000252160.HKD","LU0890818403.SGD","LU1439102457.SGD","LU0856984785.SGD","LU2317271919.USD","LU2237443549.SGD","LU1439103000.SGD","LU0029875118.USD","LU0499858438.USD","LU0823041008.USD","LU1328277881.USD","HK0000500386.USD","LU0630378429.USD","SG9999000418.SGD","LU0287142896.SGD","LU0823426308.USD","LU0531971595.HKD","HK0000320264.USD","LU0315178854.USD","LU2097828631.EUR","LU0211331839.USD","LU1868837722.USD","LU0819121731.USD","TCHI","LU0289960550.SGD","LU0611395673.USD","89988","LU1102505762.USD","LU0070217475.USD","LU0577902371.SGD","LU0165289439.USD","LU0348735423.USD","03759","LU0188438112.USD","SG9999001051.SGD","LU2237443895.HKD","LU1051768304.USD","LU1008478684.HKD","SOCL","IE00B0169N27.USD","HK0000107257.USD","LU0164865239.USD","IE00BF5LJ272.USD","LU0561508036.HKD","LU0873338254.USD","300759","HK0000252152.HKD","LU0868486357.SGD","LU2226246903.HKD","IE0009570106.USD","LU0577902538.SGD","LU0540923850.HKD","LU0501845795.SGD","02510","LU1316542783.SGD","LU0918141887.USD","03952","IE0008369823.USD","LU0588546209.SGD","BK1104","BK1615","LU1064130708.USD","LU1917777945.USD","LU2399975544.HKD","BK1183","BK1586","IE0032834883.USD","LU0029874905.USD","LU0143863784.USD","LU0469268626.HKD","LU0210533765.USD","IE0003795394.USD","LU0531970944.HKD","SG9999015978.USD","LU1105468828.SGD","03339","ALBmain","LU0117844026.USD","01308","LU0683595622.HKD","LU1226287792.SGD","LU0345769128.USD","LU0011963245.USD","LU0169518387.USD","LU0828238088.HKD","LU1044876610.USD","IE00B067MR52.USD","LU0831103253.SGD","LU0228659784.USD","LU1211504680.USD","LU0326950275.SGD","IE00BPRC5H50.USD","IE0008368411.USD","LU0327786744.USD","LU0359202008.SGD","SG9999013353.USD","LU0315179316.USD","LU0329678337.USD","LU0029874061.USD","LU0640798160.USD","LU1961090484.USD","LU0823413660.USD","BK1588","LU0192582467.USD","LU0072462343.USD","BK1171","LU1720051017.SGD","LU0348783233.USD","HK0000914660.USD","LU0228367735.SGD","LU0244354667.USD","HK0001040168.HKD","XSOE","LU1064131003.USD","LU1770034418.SGD","LU2023250504.SGD","SG9999015986.USD","LDEM","LU1718418525.SGD","LU0516422440.USD","BK1607","LU0048597586.USD","LU0828237940.HKD","LU1807302812.USD","LU0051755006.USD","LU2106854487.HKD","SGXZ81514606.USD","LU0862451753.SGD","LU1993786604.SGD","BK1095","IE00B5MMRT66.SGD","LU1794554557.SGD","BK1505","IE00B031HW06.USD","LU0865486749.SGD","LU2039709279.SGD","LU1282649810.SGD","SG9999002828.SGD","SG9999002463.SGD","LU0197773673.USD","LU2293587155.HKD","IE00B8L5B284.USD","LU1719994722.HKD","LU1720051108.HKD","BK1548","IE00B031HY20.USD","LU2177674079.SGD","LU0651947912.USD","LU0345769631.USD","BK1531","LU1366334651.USD","LU0823426480.USD","HK0000352291.HKD","LU0181495838.USD","LU0128526141.USD","IE00B0JY6N72.USD","LU3063872942.SGD","LU0572940350.SGD","IE00BMPRXR70.SGD","LU0140636845.USD","BK1155","IE00BQXX3F31.USD","LU0359201612.USD","LU1769817096.USD","IE00B543WZ88.USD","LU0648000940.SGD","HK0000914686.HKD","LU1171460220.USD","IE00BQXX3C00.GBP","LU2362540622.SGD","LU0821914370.USD","OROVY","LU0039217434.USD","LU0107464264.USD","LU1868837565.USD","06821","LU0594300419.USD","SG9999014914.USD","SGXZ51526630.SGD","BK1142","LU0972618739.USD","LU0672654166.SGD","LU2125910849.SGD","LU0320764599.SGD","LU0214875030.USD","SG9999015952.SGD","BK1618","LU0348783662.USD","LU0210527791.USD","LU0791590937.USD","LU1675838814.USD","BK1518","SG9999001069.SGD","LU0630378692.HKD","IE00B0169L03.USD","LU0543330483.HKD","LU1688375341.USD","LU0762542818.HKD","LU0345775950.USD","02269","BK1249","ODDS","BK1191","LU0588545490.SGD","LU0762540952.USD","LU0541502299.USD","LU0431992006.USD","LU0227179875.USD","LU0880133367.SGD","LU0235996351.USD","002747","002821","SG9999000459.SGD","LU2362541513.USD","01316","BK1587","LU1282651121.HKD","JADE","SG9999018865.SGD","BK1589","IE00B3M56506.USD","LU1504937902.USD","LU0359201885.HKD","LU1880398471.USD","LU2265009873.SGD","LU0106959298.USD","SG9999001226.SGD","BABA","LU0985320562.USD","LU0823038988.USD","LU1048596156.SGD","IE0003851619.USD","LU0048388663.USD","LU0229945570.USD","SG9999018857.SGD","LU0307460666.USD","LU1226288170.HKD","LU0348816934.USD","688836","00631","LU0345776255.USD","GB00BDT5M118.USD","LU2051468812.USD","LU1242518931.SGD","LU1720050803.USD","SG9999017495.SGD","LU0456842615.SGD","SG9999006514.SGD","LU2237443465.HKD","IE00B031J352.USD","LU1880383440.USD","LU0259732245.USD","LU0882747503.HKD","LU0543330566.HKD","IE0008368742.USD","002050","SG9999007991.SGD","BK1541","LU2488822045.USD","IE00BQXX3D17.EUR","IE00BZ08YS42.EUR","LU2247934214.USD","LU1152091168.USD","LU1515016050.SGD","LU1804176565.USD","LU0979878070.USD","LU1201861165.SGD","EEMX","KWEB","LU0370786039.SGD","LU2097828805.USD","LU3227948356.SGD","LU1880383366.USD","HK0000320223.HKD","IE0034224299.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461809","title":"CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461809","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461809?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:50","pubTimestamp":1787050221,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  said the new drug application for Anbenitamab in combination with its Docetaxel for Injection  was accepted by China's National Medical Products Administration.The drug, co-developed by unit Shanghai JMT-BIO Technology and Jiangsu Alphamab Oncology for the first-line treatment of advanced breast cancer, was also included in the priority review procedure.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","LU1226287792.SGD","01093","LU0067412154.USD","LU0501845795.SGD","BK1515","LU1008478684.HKD","LU0315179316.USD","LU0880133367.SGD","LU0314109678.HKD","LU1328277881.USD","LU1152091168.USD","HK0000165453.HKD","BK1521","LU1951186391.HKD","LU1993786604.SGD","IE00B031HY20.USD","LU0072913022.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1807302812.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE0008368742.USD","LU1813983027.USD","LU1152091754.HKD","LU1226287875.USD","IE00BZ08YT58.USD","IE0008369823.USD","LU1226288253.USD","LU2039709279.SGD","LU1226288170.HKD","LU1226287529.USD","LU1960683339.HKD","KURE","LU0140636845.USD","IE00BZ08YR35.GBP","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123461158","title":"Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates","url":"https://stock-news.laohu8.com/highlight/detail?id=1123461158","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123461158?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:11","pubTimestamp":1787047890,"startTime":"0","endTime":"0","summary":"Beone Medicines closed at 293.78 yuan today, up 1.34%, with a trading volume of 1.736 billion yuan, a turnover rate of 5.147%, and a volume ratio of 0.71. The company's total market capitalization...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK4139","BK4585","BK1500","BK4526","06160","LU0228659784.USD","LU1770034418.SGD","BK1583","688235","LU0307460666.USD","BK1161","LU1303224171.USD","LU2328871848.SGD","KURE","BK0239","BK4588","LU1719994722.HKD","LU1251922891.USD","ONC","LU0828237510.HKD","LU0588546209.SGD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660146646","title":"Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660146646","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660146646?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047294,"startTime":"0","endTime":"0","summary":"Alphamab Oncology says China NMPA accepts Anbenitamab NDA for first-line HER2+ advanced breast cancerChina’s NMPA accepted an NDA for anbenitamab (KN026) plus albumin-bound docetaxel HB1801 in first-l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8jzLgj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008368742.USD","LU1226287792.SGD","LU1226288170.HKD","LU1152091168.USD","01093","LU0880133367.SGD","LU1951186391.HKD","BK1574","LU2039709279.SGD","BK1191","LU0140636845.USD","LU0326950275.SGD","LU1807302812.USD","LU1226288253.USD","IE0008369823.USD","IE00BZ08YR35.GBP","LU1813983027.USD","BK1161","LU0315179316.USD","09966","IE00B543WZ88.USD","IE00BZ08YS42.EUR","LU1328277881.USD","LU1226287529.USD","LU1993786604.SGD","LU0501845795.SGD","KURE","BK1521","LU1008478684.HKD","LU0314109678.HKD","HK0000165453.HKD","LU1226287875.USD","LU0072913022.USD","IE00B5MMRT66.SGD","LU0067412154.USD","BK1515","IE00BZ08YT58.USD","IE00B031HY20.USD","LU1960683339.HKD","LU1152091754.HKD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483466","title":"CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483466?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F01I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","BK1191","LU0880133367.SGD","LU0314109678.HKD","LU1951186391.HKD","BK1521","01093","LU1226287529.USD","LU0140636845.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1226287875.USD","BK1515","LU2039709279.SGD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1008478684.HKD","HK0000165453.HKD","LU1993786604.SGD","LU0067412154.USD","LU0501845795.SGD","SG9999004220.SGD","LU1813983027.USD","LU1960683339.HKD","LU1226287792.SGD","LU0326950275.SGD","LU1152091168.USD","LU1807302812.USD","KURE","LU1152091754.HKD","LU1328277881.USD","IE00BZ08YT58.USD","LU1226288253.USD","LU0315179316.USD","LU1226288170.HKD","IE0008368742.USD","IE0008369823.USD","LU0072913022.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466107","title":"CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466107?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047263,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000165453.HKD","KURE","LU1226287529.USD","LU0326950275.SGD","LU0880133367.SGD","LU0315179316.USD","LU0501845795.SGD","LU1226287875.USD","IE0008368742.USD","LU2039709279.SGD","LU1226288170.HKD","LU1807302812.USD","LU0314109678.HKD","LU1008478684.HKD","BK1191","BK1515","01093","IE00B543WZ88.USD","IE00BZ08YT58.USD","BK1521","LU1328277881.USD","SG9999004220.SGD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU0067412154.USD","LU1152091754.HKD","LU0072913022.USD","LU1226288253.USD","LU1226287792.SGD","LU1152091168.USD","LU1960683339.HKD","LU1993786604.SGD","IE00B031HY20.USD","LU1951186391.HKD","LU0140636845.USD","IE0008369823.USD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660457502","title":"WuXi Biologics Wins BioPharma APAC Spot on 2026 Sustainable Biopharma List","url":"https://stock-news.laohu8.com/highlight/detail?id=2660457502","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660457502?lang=en_us&edition=fundamental","pubTime":"2026-08-18 15:05","pubTimestamp":1787036714,"startTime":"0","endTime":"0","summary":"WuXi Biologics wins BioPharma APAC spot on 2026 sustainable biopharma listWuXi Biologics was named to BioPharma APAC’s “Top 26” sustainable biopharma companies list for 2026.Recognition cited its Gree","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLNFzYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","LU3063872942.SGD","LU0359201612.USD","LU0516423091.SGD","LU0417516738.SGD","LU1720050803.USD","LU0588546209.SGD","LU0823426480.USD","02269","LU1794554557.SGD","LU0823426308.USD","LU0979878070.USD","LU0708995583.HKD","SG9999002562.SGD","LU0348825331.USD","BK1576","IE00B0JY6N72.USD","LU0039217434.USD","BK1521","LU0819121731.USD","LU0516422952.EUR","LU0029874061.USD","BK1610","LU0043850808.USD","LU0572944931.SGD","BK1589","LU1242518931.SGD","BK1141","LU0456846285.SGD","SG9999002463.SGD","LU0051755006.USD","LU0320764599.SGD","LU1242518857.USD","LU0326950275.SGD","LU1688375341.USD","LU0181495838.USD","LU0456827905.SGD","LU0128526141.USD","LU0516422440.USD","LU0516422366.SGD","LU0327786744.USD","LU2039709279.SGD","LU0140636845.USD","LU0307460666.USD","LU0052750758.USD","LU0856984785.SGD","LU0417516902.SGD","LU0359202008.SGD","LU0348735423.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660459040","title":"WuXi XDC Secures GMP Release for BCM3 Bioconjugate Production Line in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2660459040","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660459040?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:04","pubTimestamp":1787025881,"startTime":"0","endTime":"0","summary":"WuXi XDC secures GMP release for BCM3 bioconjugate production line in SingaporeWuXi XDC secured GMP release for its BCM3 bioconjugate production line at its Singapore site.Facility supports commercial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL21820r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU1688375341.USD","LU0823426480.USD","LU0516422366.SGD","LU0572944931.SGD","LU0052750758.USD","LU0588546209.SGD","LU1880383366.USD","LU0856984785.SGD","BK1576","BK1521","LU0326950275.SGD","LU0181495838.USD","IE00B0JY6N72.USD","LU1794554557.SGD","LU0128526141.USD","LU0327786744.USD","BK1141","LU0051755006.USD","LU0348735423.USD","LU0043850808.USD","LU0516423091.SGD","02268","LU3063872942.SGD","SG9999002562.SGD","LU2488822045.USD","LU1720050803.USD","LU0039217434.USD","SG9999002463.SGD","LU0708995583.HKD","LU0823426308.USD","LU0359202008.SGD","KURE","LU0417516738.SGD","LU0819121731.USD","LU1242518857.USD","LU0140636845.USD","LU0516422440.USD","LU0516423174.USD","LU0320764599.SGD","LU1242518931.SGD","LU0359201612.USD","LU0979878070.USD","02269","LU0417516902.SGD","LU0456827905.SGD","LU0029874061.USD","BK1589","LU0307460666.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487988","title":"CSPC Innovation Posts RMB 1.26 Billion H1 Net Profit on RMB 3.24 Billion Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487988","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487988?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:19","pubTimestamp":1786969143,"startTime":"0","endTime":"0","summary":"CSPC Innovation posts RMB 1.26 billion H1 net profit on RMB 3.24 billion revenueCSPC’s subsidiary CSPC Innovation reported 1H 2026 revenue of RMB 3.24 billion, up 208.72% year on year.Net profit attri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL28Hkdn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226288253.USD","LU2324357040.USD","LU0128525689.USD","LU0784383803.USD","AZN.UK","LU1104425308.USD","LU1983299246.USD","KURE","LU1261432733.SGD","LU0203347892.USD","LU1863844665.USD","IE00B5MMRT66.SGD","LU2091194634.USD","LU1267930490.SGD","LU0047473722.SGD","BK1515","LU0964806797.USD","LU2237443895.HKD","LU1267930813.SGD","LU1046234339.USD","01093","LU0882574055.USD","BK1521","LU1951186391.HKD","LU0140636845.USD","LU1807302812.USD","300765","LU1196032939.SGD","LU2237443622.USD","LU0738911758.USD","LU2114397693.USD","LU0784385840.USD","SGXZ57979304.SGD","LU0266013472.USD","03165","HK0000165453.HKD","LU1003077747.HKD","LU0661504455.SGD","LU0052756011.USD","LU1023059063.AUD","LU1960683339.HKD","IE00B543WZ88.USD","LU0315179316.USD","LU0390134368.USD","LU0920840948.USD","LU1226288170.HKD","LU2112291526.USD","LU1061106388.HKD","LU3187612489.SGD","LU0211326839.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}